This report provides a comprehensive analysis of the platelet rich plasma market in Asia Pacific considering various macro as well as microeconomic factors such as regulations, applications of platelet rich plasma, and advantages and disadvantages of type of platelet rich plasma, and cost. The report studies the platelet rich plasma market from four perspectives: type of platelet rich plasma, origin of platelet rich plasma, application of platelet rich plasma, and country wise market.
Based on the type of platelet rich plasma, the market in Asia Pacific has been segmented into pure platelet rich plasma, leucocytes and platelet rich plasma, and platelet rich fibrin. Based on origin, the market has been segmented into autologous platelet rich plasma, allogeneic platelet rich plasma, and homologous platelet rich plasma. In terms of the application of platelet rich plasma, the market has been segmented into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery, and other surgeries. In terms of country, the market has been studied for eleven major geographies: Australia, the Philippines, China, India, Singapore, Thailand, Malaysia, South Korea, Hong Kong, Taiwan, and Rest of Asia Pacific. Additionally, each segment of the platelet rich plasma market has been further subdivided into national markets.
The market size for each of the segments and sub-segments mentioned above is provided in US$ Mn considering 2013 and 2014 as base years and forecast from 2015 to 2023. The forecast model considers various factors such as number of surgeries, health care expenditure of the country, advantages of the individual segment, penetration of platelet rich plasma therapy in the country, the cost of platelet rich plasma in various countries, and government regulations. The research methodology is a blend of primary as well as secondary market research, where market estimates based on desk research are further refined considering inputs from expert interviews.
This report on the platelet rich plasma market in Asia Pacific also provides qualitative information on major players in the market. It also includes details on current regulatory policies for platelet rich plasma and devices. Major factors driving and restraining the platelet rich plasma market are also discussed in the report, while opportunities from the future perspective are also mentioned. Furthermore, the platelet rich plasma market report provides value chain analysis for comprehensive analysis. Porter’s Five Forces Analysis will provide the idea of bargaining power of buyers, bargaining power of suppliers, threat of new entrants in platelet rich plasma market, threat of substitutes, and competitive rivalry in platelet rich plasma market. Additionally, market share analysis of the platelet rich plasma market in Asia Pacific provides detailed information on current competitive landscape of the market. Market attractiveness analysis provides information on most attractive countries for platelet rich plasma.
Finally, the report profiles major players in the platelet rich plasma market in Asia Pacific including Harvest Technology, Arthrex, Inc., Stryker Corporation, Zimmer Biomet, DePuy Synthes, AdiStem Ltd., Cesca Therapeutics, Inc., Exactech, Inc., and Rmedica Co. Ltd. Each of the companies is profiled for parameters such as company overview, financial overview, product portfolio, business strategies, and recent developments. The report on the platelet rich plasma market estimation and forecast comprises 128 slides and 68 graphs.
Table of Content
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
2. Executive Summary
2.1 Market Snapshot
3. Asia Pacific Platelet Rich Plasma Market Overview
3.2 Value Chain Analysis
3.3 Regulatory Framework
3.4 Market Dynamics
3.5 Porter’s Five Force Analysis
3.5.1 Bargaining Power of Buyers
3.5.2 Bargaining Power of Suppliers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis of the Asia Pacific Platelet Rich Plasma Market, by Country, 2014
3.7 Competitive Landscape: Market Share Analysis by Key Players, 2014 (Value, %)
4. Asia Pacific Platelet Rich Plasma Market Revenue, by Type, 2013–2023 (US$ Mn)
4.2 Pure Platelet-Rich Plasma (P-PRP) Market Revenue, by Country, 2013–2023 (US$ Mn)
4.2.9 Hong Kong
4.2.11 Rest of APAC (Indonesia, New Zealand, Vietnam, etc.)
4.3 Leukocyte-Rich Platelet-Rich Plasma (L-PRP)*
4.4 Pure Platelet-Rich Fibrin (P-PRF)/ Leukocyte-Rich Platelet-Rich Fibrin (L-PRF)*
5. Asia Pacific Platelet Rich Plasma Market Revenue, by Origin, 2013–2023 (US$ Mn)
5.2 Autologous Platelet-Rich Plasma
5.2.9 Hong Kong
5.2.11 Rest of APAC (Indonesia, New Zealand, Vietnam, etc.)
5.3 Allogeneic Platelet-Rich Plasma*
5.4 Homologous Platelet-Rich Plasma*
6. Asia Pacific Platelet Rich Plasma Market Revenue, by Application, 2013–2023 (US$ Mn)
6.2 Orthopedic Surgery
6.2.9 Hong Kong
6.2.11 Rest of APAC (Indonesia, New Zealand, Vietnam, etc.)
6.3 Cosmetic Surgery*
6.4 General Surgery*
6.6 Other Surgeries (Urology, Cardiothoracic, Oral & Maxillofacial and Periodontal)*
7. Asia Pacific Platelet Rich Plasma Market Revenue, by Country, 2013–2023 (US$ Mn)
7.10 Hong Kong
7.12 Rest of APAC (Indonesia, New Zealand, Vietnam, etc.)
9. Company Profiles
9.1 AdiStem Ltd.
9.2 Arthrex, Inc.
9.3 Biomet, Inc.
9.4 Cesca Therapeutics, Inc.
9.5 DePuy Synthes, Inc.
9.6 Exactech, Inc.
9.7 Harvest Technologies Corp.
9.8 NeoGenesis Co. Ltd.
9.9 Rmedica Co. Ltd.
9.10 Stryker Corporation
9.11 Seawon Meditech
*: Similar country wise analysis provided for all other segments
Make an enquiry before buying this Report
Please fill the enquiry form below.